POZZI, Samantha
POZZI, Samantha
Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto
5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells.
2007 T., Kiziltepe; T., Hideshima; L., Catley; N., Raje; H., Yasui; N., Shiraishi; Y., Okawa; H., Ikeda; S., Vallet; Pozzi, Samantha; K., Ishitsuka; E. M., Ocio; D., Chauhan; K. C., Anderson
A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) Infection
2008 R., Guariglia; Luminari, Stefano; A., De Renzo; E., Iannitto; M., Dell'Olio; Pozzi, Samantha; T., Pierri; L., D'Amato; A., Traficante; Sacchi, Stefano; P., Musto
A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) InfectionBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3054
2008 Roberto, Guariglia; Luminari, Stefano; Amalia De, Renzo; Emilio, Iannitto; Matteo, Dell’Olio; Pozzi, Samantha; Teresa, Pierri; Lucia, D’Amato; Antonio, Traficante; Sacchi, Stefano; Pellegrino, Musto
A concise review of lenalidomide therapy for follicular lymphoma
2017 Bari, Alessia; Marcheselli, Raffaella; Barbolini, Monica; Ferri, Paola; Sacchi, Stefano; Pozzi, Samantha
A high-affinity fully human anti-IL-6 mAb (OP-R003-1, 1339) for the treatment of Multiple Myeloma
2009 M. T., Fulciniti; T., Hideshima; C., Vermot Desroches; Pozzi, Samantha; P., Nanjappa; Z., Shen; N., Patel; E. S., Smith; R., Prabhala; Y., Tai; P., Tassone; K. C., Anderson; N. C., Munshi
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL)
2006 Luminari, Stefano; Marcheselli, Luigi; I., Mancarella; Bellei, Monica; Montanini, Antonella; C., Mammi; E., Barbolini; Cesaretti, Marina; Pozzi, Samantha; M., Lombardo; Sacchi, Stefano; Federico, Massimo
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up
2017 Bari, Alessia; Marcheselli, Raffaella; Marcheselli, Luigi; Alvarez, Isabel; Pozzi, Samantha; Ferri, Paola; Lazzaro, Antonio; Fragasso, Alberto; Neri, Santo; Baldini, Luca; Carella, Angelo Michele; Angrilli, Francesco; Guariglia, Roberto; Buda, Gabriele; Stelitano, Caterina; Sacchi, Stefano
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
2011 S., Vallet; Pozzi, Samantha; K., Patel; N., Vaghela; M. T., Fulciniti; P., Veiby; T., Hideshima; L., Santo; D., Cirstea; D. T., Scadden; K. C., Anderson; N., Raje
A RANDOMIZED PHASE II STUDY (GISL - MM03 TRIAL) WITH ORAL MELPHALAN+ PREDNISONE (MP) VERSUS MELPHALAN, + PREDNISONE + THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA
2009 Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha; Bari, Alessia; O., Ciarcia; L., Masini; A., Lazzaro; F., Morabito; A., Fragasso; N., Di Renzo; G., Quarta; G., Buda; P., Musto; M. L., Vigliotti; A., Pastorini; M., Brugiatelli
A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery
2003 Marietta, M.; Bertesi, M.; Simoni, L.; Pozzi, S.; Castelli, I.; Cappi, C.; Torelli, G.
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients
2015 Tadmor, Tamar; Bari, Alessia; Marcheselli, Luigi; Sacchi, Stefano; Aviv, Ariel; Baldini, Luca; Gobbi, Paolo G.; Pozzi, Samantha; Ferri, Paola; Cox, Maria Christina; Cascavilla, Nicola; Iannitto, Emilio; Federico, Massimo; Polliack, Aaron
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients
2018 Bari, Alessia; Marcheselli, Luigi; Marcheselli, Raffaella; Pozzi, Samantha; Cox, Maria Christina; Baldessari, Cinzia; Ferri, Paola; Gobbi, Paolo; Baldini, Luca; Tadmor, Tamar; Musto, Pellegrino; Federico, Massimo; Sacchi, Stefano
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
2009 Federico, Massimo; Luminari, Stefano; Iannitto, E; Polimeno, G; Marcheselli, Luigi; Montanini, Antonella; LA SALA, A; Merli, F; Stelitano, C; Pozzi, Samantha; Scalone, R; DI RENZO, N; Musto, P; Baldini, L; Cervetti, G; Angrilli, F; Mazza, P; Brugiatelli, M; Gobbi, Pg
Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report
2003 M., Marietta; Pozzi, Samantha; Luppi, Mario; M., Bertesi; C., Cappi; M., Morselli; Torelli, Giuseppe
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
2010 S., Vallet; S., Mukherjee; N., Vaghela; T., Hideshima; M., Fulciniti; Pozzi, Samantha; L., Santo; D., Cirstea; K., Patel; A. R., Sohani; A., Guimaraes; W., Xie; D., Chauhan; J. A., Schoonmaker; E., Attar; M., Churchill; E., Weller; N., Munshi; J. S., Seehra; R., Weissleder; K. C., Anderson; D. T., Scadden; N., Raje
Activity of BKM120 and BEZ235 against lymphoma cells
2015 Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Bari, Alessia; Ferri, Paola; Sacchi, Stefano
Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.
2005 Pozzi, Samantha; Marcheselli, Raffaella; Sacchi, Stefano; Giovanni, Quarta; Pellegrino, Musto; Giuseppe, Caparrotti; Donato, Natale; Graziano, Pianezze; Giuseppe, Polimeno; Vincenzo, Pitini; Luisa, Ponchio; Chiara, Broglia; Mauro, Spriano; Maurizio, Musso; Luciano, Masini; Amedea, Donelli; Daniele, Dini; Giovanna, Leonardi; Luminari, Stefano; Giuseppe, Pollastri
Anthracycline-Fludarabine Containing Regimens with or without Rituximab in the Treatment of Advanced Follicular Lymphoma Patients
2008 Sacchi, Stefano; Marcheselli, Luigi; Pozzi, Samantha; Bari, Alessia; Luminari, Stefano; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini; M., Spriano; G., Caparrotti; M., Musso; G., Quarta; M., Brugiatelli
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
2009 Luminari, Stefano; Marcheselli, Luigi; Sacchi, Stefano; Pozzi, Samantha; Bari, Alessia; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini
Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide.
2011 L., Santo; T., Hideshima; D., Cirstea; M., Bandi; E. A., Nelson; G., Gorgun; S., Rodig; S., Vallet; Pozzi, Samantha; K., Patel; C., Unitt; M., Squires; Y., Hu; D., Chauhan; A., Mahindra; N. C., Munshi; K. C., Anderson; N., Raje
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. | 1-gen-2007 | T., Kiziltepe; T., Hideshima; L., Catley; N., Raje; H., Yasui; N., Shiraishi; Y., Okawa; H., Ikeda; S., Vallet; Pozzi, Samantha; K., Ishitsuka; E. M., Ocio; D., Chauhan; K. C., Anderson | |
A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) Infection | 1-gen-2008 | R., Guariglia; Luminari, Stefano; A., De Renzo; E., Iannitto; M., Dell'Olio; Pozzi, Samantha; T., Pierri; L., D'Amato; A., Traficante; Sacchi, Stefano; P., Musto | |
A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) InfectionBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3054 | 1-gen-2008 | Roberto, Guariglia; Luminari, Stefano; Amalia De, Renzo; Emilio, Iannitto; Matteo, Dell’Olio; Pozzi, Samantha; Teresa, Pierri; Lucia, D’Amato; Antonio, Traficante; Sacchi, Stefano; Pellegrino, Musto | |
A concise review of lenalidomide therapy for follicular lymphoma | 1-gen-2017 | Bari, Alessia; Marcheselli, Raffaella; Barbolini, Monica; Ferri, Paola; Sacchi, Stefano; Pozzi, Samantha | |
A high-affinity fully human anti-IL-6 mAb (OP-R003-1, 1339) for the treatment of Multiple Myeloma | 1-gen-2009 | M. T., Fulciniti; T., Hideshima; C., Vermot Desroches; Pozzi, Samantha; P., Nanjappa; Z., Shen; N., Patel; E. S., Smith; R., Prabhala; Y., Tai; P., Tassone; K. C., Anderson; N. C., Munshi | |
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) | 1-gen-2006 | Luminari, Stefano; Marcheselli, Luigi; I., Mancarella; Bellei, Monica; Montanini, Antonella; C., Mammi; E., Barbolini; Cesaretti, Marina; Pozzi, Samantha; M., Lombardo; Sacchi, Stefano; Federico, Massimo | |
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up | 1-gen-2017 | Bari, Alessia; Marcheselli, Raffaella; Marcheselli, Luigi; Alvarez, Isabel; Pozzi, Samantha; Ferri, Paola; Lazzaro, Antonio; Fragasso, Alberto; Neri, Santo; Baldini, Luca; Carella, Angelo Michele; Angrilli, Francesco; Guariglia, Roberto; Buda, Gabriele; Stelitano, Caterina; Sacchi, Stefano | |
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function. | 1-gen-2011 | S., Vallet; Pozzi, Samantha; K., Patel; N., Vaghela; M. T., Fulciniti; P., Veiby; T., Hideshima; L., Santo; D., Cirstea; D. T., Scadden; K. C., Anderson; N., Raje | |
A RANDOMIZED PHASE II STUDY (GISL - MM03 TRIAL) WITH ORAL MELPHALAN+ PREDNISONE (MP) VERSUS MELPHALAN, + PREDNISONE + THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA | 1-gen-2009 | Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha; Bari, Alessia; O., Ciarcia; L., Masini; A., Lazzaro; F., Morabito; A., Fragasso; N., Di Renzo; G., Quarta; G., Buda; P., Musto; M. L., Vigliotti; A., Pastorini; M., Brugiatelli | |
A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery | 1-gen-2003 | Marietta, M.; Bertesi, M.; Simoni, L.; Pozzi, S.; Castelli, I.; Cappi, C.; Torelli, G. | |
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients | 1-gen-2015 | Tadmor, Tamar; Bari, Alessia; Marcheselli, Luigi; Sacchi, Stefano; Aviv, Ariel; Baldini, Luca; Gobbi, Paolo G.; Pozzi, Samantha; Ferri, Paola; Cox, Maria Christina; Cascavilla, Nicola; Iannitto, Emilio; Federico, Massimo; Polliack, Aaron | |
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients | 1-gen-2018 | Bari, Alessia; Marcheselli, Luigi; Marcheselli, Raffaella; Pozzi, Samantha; Cox, Maria Christina; Baldessari, Cinzia; Ferri, Paola; Gobbi, Paolo; Baldini, Luca; Tadmor, Tamar; Musto, Pellegrino; Federico, Massimo; Sacchi, Stefano | |
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. | 1-gen-2009 | Federico, Massimo; Luminari, Stefano; Iannitto, E; Polimeno, G; Marcheselli, Luigi; Montanini, Antonella; LA SALA, A; Merli, F; Stelitano, C; Pozzi, Samantha; Scalone, R; DI RENZO, N; Musto, P; Baldini, L; Cervetti, G; Angrilli, F; Mazza, P; Brugiatelli, M; Gobbi, Pg | |
Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report | 1-gen-2003 | M., Marietta; Pozzi, Samantha; Luppi, Mario; M., Bertesi; C., Cappi; M., Morselli; Torelli, Giuseppe | |
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease | 1-gen-2010 | S., Vallet; S., Mukherjee; N., Vaghela; T., Hideshima; M., Fulciniti; Pozzi, Samantha; L., Santo; D., Cirstea; K., Patel; A. R., Sohani; A., Guimaraes; W., Xie; D., Chauhan; J. A., Schoonmaker; E., Attar; M., Churchill; E., Weller; N., Munshi; J. S., Seehra; R., Weissleder; K. C., Anderson; D. T., Scadden; N., Raje | |
Activity of BKM120 and BEZ235 against lymphoma cells | 1-gen-2015 | Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Bari, Alessia; Ferri, Paola; Sacchi, Stefano | |
Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw. | 1-gen-2005 | Pozzi, Samantha; Marcheselli, Raffaella; Sacchi, Stefano; Giovanni, Quarta; Pellegrino, Musto; Giuseppe, Caparrotti; Donato, Natale; Graziano, Pianezze; Giuseppe, Polimeno; Vincenzo, Pitini; Luisa, Ponchio; Chiara, Broglia; Mauro, Spriano; Maurizio, Musso; Luciano, Masini; Amedea, Donelli; Daniele, Dini; Giovanna, Leonardi; Luminari, Stefano; Giuseppe, Pollastri | |
Anthracycline-Fludarabine Containing Regimens with or without Rituximab in the Treatment of Advanced Follicular Lymphoma Patients | 1-gen-2008 | Sacchi, Stefano; Marcheselli, Luigi; Pozzi, Samantha; Bari, Alessia; Luminari, Stefano; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini; M., Spriano; G., Caparrotti; M., Musso; G., Quarta; M., Brugiatelli | |
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma. | 1-gen-2009 | Luminari, Stefano; Marcheselli, Luigi; Sacchi, Stefano; Pozzi, Samantha; Bari, Alessia; F., Ilariucci; C., Stelitano; F., Angrilli; A., Lazzaro; L., Baldini | |
Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide. | 1-gen-2011 | L., Santo; T., Hideshima; D., Cirstea; M., Bandi; E. A., Nelson; G., Gorgun; S., Rodig; S., Vallet; Pozzi, Samantha; K., Patel; C., Unitt; M., Squires; Y., Hu; D., Chauhan; A., Mahindra; N. C., Munshi; K. C., Anderson; N., Raje |